Reduced initial Pazopanib dosing strategy for recurrent, advanced, or metastatic sarcoma: A single center experience
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Fields of Study & Subjects
Publication details
- Journal / source
- Journal of Oncology Pharmacy Practice
- Pages
- 10781552251414698–10781552251414698
- Publication date
- 21 March 2026
- Language
- EN